Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) Raises $20 Million From Direct Offering


Dallas, Texas 02/11/2014 (FINANCIALSTRENDS) – The $185 million market capped drug maker Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) has disclosed that    it has in principal given its go ahead to sell $20 million units worth of its stock in the form of direct offering. The price per unit for this price offering has been fixed at $1.05 per unit. The unit has been defined as one share of common stock and a warrant which has a 5 year term. The warrant will offer option to purchase ¼th of a single share of common stock at a inflated price of $1.28 per share.

A total of 19.05 million shares of common stock are expected to be offered for sale in addition to the 4.76 million shares in lieu of the warrants that become exercisable. Total proceeds from the sale of all these stakes is expected to net the firm close to $20 million in proceeds. The offer closed on 21st January.

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN)  had retained the services of Roth Capital Partners to act as its lead placement agent. H.C. Wainwright & Co., LLC had been appointed as the co-placement agent.  The $20 million thus raised is to be used for further enhancing the company’s ongoing clinical trail programs. The key target drugs which are going through the development stage are “Archexin®, RX-3117, and SupinoxinTM (RX-5902)”.

Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) also disclosed that its Chief Executive Officer Peter Suzdak, PhD presented at the 16th Annual BIO CEO & Investor Conference on 10th February and hopes to attract a slew of new institutional investors to buy into their stock on the back of strong potential held by its drug pipeline.

The stock of Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) was down 5 percent during trading on 10th February and price per share had settled at $1.12.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.